Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03379428
Title Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors US Oncology Research
Indications

Her2-receptor positive breast cancer

Therapies

Trastuzumab

Ibrutinib + Trastuzumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.